BiotechTube
Home/AC Immune/Günther Staffler
GS

Günther Staffler

EVP, Development

AC Immune

Therapeutic Areas

Alzheimer's DiseaseParkinson's DiseaseNeurodegenerative Diseases

AC Immune Pipeline

DrugIndicationPhase
ACI-7104.056 (VacSYn)Parkinson's DiseasePhase 2
Anti-Abeta active immunotherapyAlzheimer's Disease (Prevention)Phase 2
ACI-35.130Alzheimer's DiseasePhase 1b/2
SemorinemabAlzheimer's DiseasePhase 2
Morphomer Tau aggregation inhibitor (e.g., ACI-3024)Alzheimer's DiseasePhase 1
ACI-12589TDP-43 proteinopathies (e.g., ALS)Preclinical
ACI-19626 (TDP-43 PET Tracer)Diagnostic for TDP-43 proteinopathiesPreclinical
Alpha-synuclein PET TracerDiagnostic for Parkinson's DiseasePhase 1

Leadership Team at AC Immune

PA
Prof. Andrea Pfeifer
Co-Founder, Chief Executive Officer and Director
CR
Christopher Roberts
Chief Financial Officer
PD
Piergiorgio Donati
Chief Operating Officer
DC
Dr. Catherine Mummery
Chair of Clinical Advisory Board
View full AC Immune profile